Press Releases

Aptar Pharma’s Nasal Unidose Device Approved for TosymraTM Sumatriptan Spray

Aptar Pharma, a leading provider of drug delivery devices worldwide and part of AptarGroup, Inc. announced that its patented Unidose Liquid System is the device which delivers TosymraTM (sumatriptan) Nasal Spray 10mg, for the acute treatment of migraine in...

Novel silica delivery system Nuvec (R) enters final pre-clinical development stage

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, has announced results fromthe company’s latest research study into its novel silica nanoparticle for cancer treatments and vaccines, Nuvec®. The work, which repeated and expanded on a previouspDNA OVA study,...

NSG BioLabs To Launch Singapore’s First And Largest Private Co-Working Laboratory And Office Space

NSG BioLabs, a Singapore-based company established to incubate and support growing life sciences companies via a conducive R&D environment, announced that it will be launching a co-working laboratory and office space aimed at developing innovative biotechnology firm in November...

Signant Health Proudly Sponsors “DISORDER: The Rare Disease Film Festival” to Raise Awareness and Hope for Millions of Families Worldwide

There are 7,000 recognized rare disease conditions that affect between 25 and 30 million people in the United States alone, and the vast majority are totally unknown in the community. What if there was a film to bring each...

Hospital Angelina Caron joins the Patient Network Explorer platform, expanding Clinerion’s global hospital network in Brazil

Hospital Angelina Caron, of Campina Grande do Sul, Paraná, is the latest Brazilian hospital to join Clinerion’s network of partner hospitals on its Patient Network Explorer platform. Hospital Angelina Caron has nearly one million patients and specializes in cardiology,...

DuPont to Enter Strategic Collaboration on Probiotics with BY-HEALTH

Satisfying consumers’ growing demands for probiotics for everyday life DuPont Nutrition & Biosciences today announced its intent to enter into a strategic collaboration with BY-HEALTH, a leading consumer health care company in China. The strategic collaboration would focus generally on research...

Sygnature Discovery moves US base to Kendall Square

Sygnature Discovery, the leading independent drug discovery and pre-clinical services company, has announced its US office has moved. The new office, at 245 First Street in Cambridge, MA, is near Kendall Square, the heart of the Cambridge–Boston biotech hub. It’s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read